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Abstract  
In the maxillofacial skeleton, chronic osteomyelitis is more often observed in the mandible than 
maxilla. Maxillary osteomyelitis is rare because of its rich blood supply. It is usually seen in 
individuals with impaired immune response, uncontrolled diabetes and hospitalized patients. It can 
be caused by bacterial, fungal or viral infections. We report a rare case of maxillary osteomyelitis 
caused by an emerging mucormycete, Apophysomyces variabilis. 
 
 
 
 
 
 
 
 
  
 
 
 
 
Introduction 
Osteomyelitis of maxilla is a very rare 
pathology, the gravity of which was appreciated by 
Hippocrates as long ago as the 5th century BC [1]. It 
is seen less frequently because maxillary blood supply 
is more extensive as compared to the mandible. Thin 
cortical plates and a relative paucity of medullary 
tissue in the maxilla preclude confinement of 
infections within bone and permit the dissipation of 
edema and pus into the soft tissues and the paranasal 
sinuses [2].  
The pathogenesis of osteomyelitis may be 
induced either by hematogenous origin or by 
dissemination of local infections, and its treatment 
involves removal of bone sequestra, lesion 
debridement, and bone decortication associated with 
systemic antibiotic therapy [3, 4]. The occurrence, 
type, severity and clinical prognosis of osteomyelitis 
depend upon several factors, including the 
characteristics and virulence of the infecting 
pathogen, host immune response and source of 
infection [5]. However, in some patients, these 
infections are refractory to surgery and antibiotic 
therapy [3], requiring an adequate microbiological 
diagnosis [4, 6].
 
In most of the cases the causative organism 
is Staphylococcus aureus or Staphylococcus 
epidermidis. Occasionally, anaerobic or 
microaerophilic cocci and Gram-negative organisms 
such as Klebsiella, Pseudomonas and Proteus spp., 
are found in association with the other pathogens. 
Fungal osteomyelitis is mostly caused by Aspergillus, 
Mucor spp [7]. Here, we report a case of bilateral 
maxillary osteomyelitis caused by Apophysomyces 
variabilis. 
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Case report 
A 32 year old male reported to the department 
of oral medicine and radiology with a six-month history 
of a non-healing wound in the maxilla. There was a 
history of pain in upper right back area seven months 
ago. He went to a private dentist who extracted his 
maxillary right third molar. There was no history of 
fever, purulent discharge, paraesthesia or foul odor. 
The patient reported that even after extraction 
there was no relief from pain but instead it had started 
radiating to the anterior region of right maxilla. The 
site of extraction did not heal even after taking 
repeated courses of antibiotics. Patient then went to 
the private hospital where a CT scan was taken. He 
was then treated with empiric intravenous antibiotics 
for a period of 14 days and oral antibiotics thereafter 
for a period of 1 month. There was slight relief from 
pain. 
 
Figure 1: Intra oral view showing exposed necrotic bone in 16, 17 
region. 
At the time of presentation to our hospital, the 
medical history of the patient was non-contributory 
and the vital signs were stable. There were no risk 
factors for human immunodeficiency virus infection or 
tuberculosis. A nasal twang was noticed in the 
patients' voice. Inspection revealed a diffuse irregular 
swelling on the both sides of the maxilla. 
Intra oral examination revealed a mucosal 
defect in the right maxillary molar region, with 
exposed necrotic bone in 16, 17 region (Figure 1). All 
maxillary teeth (17-27) were mobile. The right 
maxillary third molar was missing. Spacing was 
noticed between 11 and 21. Diffuse swelling was 
noticed on the hard palate (Figure 2). 
 
Figure 2: Edema seen over the palate. 
 
Figure 3: Past CT scan showing mid palatal dehiscence and break 
in the continuity of the lateral and medial walls of the bilateral 
maxillary sinus in the affected area. 
 
Past medical records were assessed. The 
past CT scan (taken 5 months back) showed 
dehiscence of the mid-palatal suture (Figure 3) and 
break in the continuity of the lateral and medial walls 
of both maxillary sinuses. Polyps were also noticed in 
bilateral sinuses. The patient was asked to undergo a 
new set of investigations including CT scan, 
biochemical investigations, biopsy, and culture 
sensitivity. 
The present CT scan showed marked 
destruction of maxillary alveoli with enhancing soft 
tissue density extending into bilateral maxillary 
sinuses and left nasal cavity. Bony resorption of the 
posterolateral wall of bilateral maxillary sinuses was 
also evident (Figure 4, 5). 
 
Figure 4: New CT scan showing marked destruction of the palate 
(coronal view). 
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Biochemical investigations revealed normal 
blood sugar levels. Fasting blood sugar was 90 mg/dl 
& postprandial blood sugar level was 138 mg/dl. 
Routine blood investigations revealed - hemoglobin 14 
gm%, total leukocyte count - 17,500/µl, serum 
electrolytes:- total calcium – 10 mg/dl, chloride – 98 
mEq/l, potassium - 4.2 mEq/l, sodium-138 mEq/l and 
creatinine – 1 mg/dl. 
 
Figure 5: Axial view showing osteolytic lesion involving bilateral 
maxilla. 
 
Among the clinical differential diagnosis we 
considered osteomyelitis (fungal) secondary to 
traumatic extraction, pre-existing fungal sinusitis 
which was now involving the surrounding bone, 
squamous cell carcinoma of maxillary sinus, 
malignant salivary gland tumor arising from the 
accessory glands of the palate, Wegener’s 
granulomatosis, bone necrosis as an extension of 
infections such as acute necrotizing ulcerative 
gingivitis (ANUG) from the gingiva to bone. 
A biopsy of the involved tissue was taken. 
Hard tissue specimen along with the adjacent soft 
tissue was excised under local anesthesia and sent 
for histopathological examination. The culture and 
sensitivity tests were also performed. 
 
Figure 6: Floccose, white, fungal colonies of a mucomycete on 
Sabouraud dextrose agar. 
Routine bacteriological cultures of the 
debrided tissue yielded Pseudomonas aeruginosa and 
Staphylococcus aureus. Cultures of debrided tissue 
on Sabouraud dextrose agar containing 
chloramphenicol and on Sabouraud dextrose agar 
containing chloramphenicol and cycloheximide yielded 
floccose, white to dirty-white, fast-growing fungal 
colonies of a mucormycete (Figure 6). The plates 
were incubated at 37°C in the dark for 7 days. Direct 
microscopy showed evidence of broad, aseptate, or 
sparsely septate ribbon-like hyphae with right-angled 
branching in stained sections of tissue specimens. 
The apophyses were dark, funnel or champagne glass 
shaped (Figure 7). The isolates were identified as 
Apophysomyces elegans Complex on morphological 
basis. The mold did not sporulate when subcultured 
on several routinely used mycological media. 
 
Figure 7: Lactophenol cotton blue staining of culture isolate 
demonstrating sporangiophores terminating in funnel-shaped 
apophyses. (magnification, x 400). 
 
The isolate was then sent to the Universitat 
Rovira i Virgili (Reus, Spain) for molecular analysis 
and was found to be Apophysomyces variabilis. 
(Gene bank accession no for the isolate is 
HE792980). 
 
Figure 8: Post operative CT scan after debridement of the lesion 
(axial view). 
The final diagnosis of maxillary osteomyelitis 
caused by Apophysomyces variabilis was made. The 
lesion was surgically debrided under general 
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anesthesia. He was started on amphotericin B 
0.8mg/kg/day intravenously (i.v.) for two weeks. It was 
slowly infused over 4-6 hours and blood urea and 
creatinine levels were monitored as the drug can 
cause renal toxicity. Cefepime (i.v.) 50mg/kg body 
weight 12 hourly was also prescribed for ten days.         
CT scan was repeated again after debridement 
(Figure 8). 
 
Figure 9: Post operative clinical photograph. 
 
Follow-up clinical examination up to one year 
showed no evidence of persistent infection (Figure 9). 
 
Discussion 
Chronic osteomyelitis is a relapsing and 
persistent infection that evolves over months to years 
and is characterized by low-grade inflammation, 
presence of bone sequestra, new bone apposition 
and, sometimes fistulous tracts [8]. Odontogenic 
infection is the most common cause of osteomyelitis 
of the jaws, although other causes including injury, 
malnutrition, diabetes mellitus, malignant tumors, 
corticosteroid therapy, immunosuppressive drugs, 
leucopenia, chronic systemic and infectious diseases 
occurring in hypovascularized bone may be 
associated with this condition [9-11].
 
The most common presenting signs and 
symptoms of maxillary osteomyelitis include fever, 
headache, sinusitis, facial pain and swelling, mucosal 
ulceration and/or necrosis. Radiographic feature is an 
ill-defined osteolytic lesion with loss of lamina dura. 
Diagnosis is based on clinical picture revealing the 
invasive course of the disease and by culture and 
histopathology. In our case also, the clinical signs and 
radiographic features did not vary from the other usual 
causes of maxillary osteomyelitis. Routine culture on 
Sabouraud dextrose agar containing chloramphenicol 
helped to identify Apophysomyces species. 
Apophysomyces is a member of the fungal 
class Mucormycetes, order Mucorales. Although 
mucormycetes are ubiquitous environmental 
pathogens, disease from Apophysomyces is rare. In a 
study it has been proved that A. elegans could not be 
isolated from hospital environment [12]. It is an 
emerging pathogen that, unlike the other members of 
Mucorales, has been reported to cause invasive 
cutaneous, renal, abdominal and rhino-orbitocerebral 
infections in immunocompetent individuals [13]. The 
infection typically follows traumatic implantation of the 
agent but may also result from inhalation of spores 
into the sinus [14, 15].
 
Excellent mycelial growth is seen on standard 
culture media (Sabouraud’s dextrose medium). It 
grows as a floccose aerial mycelium, demonstrating 
white to grey confluent growth in 2 days on standard 
culture medium [16]. A special nutrient-deficient 
growth medium, a high temperature of incubation and 
prolonged incubation can be used to induce A. 
elegans isolates to sporulate [13, 16-18].  A. elegans 
is a thermotolerant fungus that is capable of rapid 
growth at 24-43° C in vitro [10, 19, 20] and it is 
believed that this thermotolerance permits fungal 
proliferation in deep tissues. Although no specific 
virulence factors have yet been identified for this 
organism, it produces disease in much the same way 
as the other mucorales, with tissue and angio-invasion 
[16]. 
The KOH wet mount can also be done which 
demonstrates broad aseptate hyphae with right-
angled branching. The growth obtained on culture are 
identified by colony characteristics, lactophenol cotton 
blue preparation and slide culture. For sporulation, 
agar flotation method is used i.e. one cm SDA agar 
blocks permeated with hyphae and accompanying 
aerial hyphae are cut and placed on surface of sterile 
water-yeast extract solution [21].
 
Apophysomyces elegans Complex now 
includes four species - Apophysomyces elegans, A. 
ossiformis, A. trapeziformis and A. variabilis - with 
genetic, physiological and morphological differences 
[21]. The differences in morphology of 
sporangiophores and sporangiospores correlate with 
the different phylogenetic species. The strains of A. 
variabilis show morphological diversity. The 
sporangiospores range from broadly clavate to 
ellipsoidal with flattening on one side. The strains of A. 
elegans, show ovoid, subspherical, broadly ellipsoidal 
to barrel shaped sporangiospores and are the largest 
among the different species in the complex. The 
sporangiospores of A. trapeziformis are trapezoidal 
and smaller while those of Apophysomyces ossiformis 
are thick-walled and clearly biconcave (bone-shaped) 
[22, 23].
 
Aggressive management including surgical 
intervention with or without medical therapy is 
required for the treatment of Apophysomyces spp. 
infections [14]. Surgical removal of infected tissue 
provides a more definitive treatment, while the 
response to amphotericin B is variable at best. 
Liposomal encapsulation of amphotericin may 
facilitate deposition of the drug into the 
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reticuloendothelial system and higher dose 
concentrations in the central nervous system, 
resulting in increased efficacy. It also appears to 
enhance delivery to fungi, infected organs, and 
phagocytes [24]. The toxicity is decreased significantly 
enabling higher dosages to be administered. 
Posaconazole, a new triazole, can be a good 
alternative in patients with amphotericin B associated 
toxicity. The initial dose of 200 mg four times a day 
can be changed to 400 mg twice a day once the 
patient is clinically stable and is tolerating the 
medication. Advantages of this medication are its oral 
formulation, a favorable safety profile, an adequate 
oral bioavailability and good tolerance, which makes it 
much easier to manage the patients on an ambulatory 
basis once they are clinically stable [25].
 
Although most cases of infection with A. 
variabilis fungi have been reported in India [14], 
infections with this fungus may have a wider 
distribution. A recent study demonstrated that this 
species represented 0.5% of fungi of the order 
Mucorales isolated from clinical samples in the United 
States [26]. Apophysomyces can cause cutaneous, 
renal, abdominal, rhino-orbito-cerebral and 
disseminated infections in the host. Furthermore, a 
high mortality rate and the fact that most of these 
infections involve otherwise healthy patients make this 
a serious infection. 
In our case, along with Apophysomyces sp. 
we were also able to culture Staphylococcus aureus 
and Pseudomonas aeruginosa. Mixed anaerobic 
infections are common in osteomyelitis, especially in 
jaw infections. Several fastidious strictly anaerobic 
bacteria commonly present in the dental biofilm can 
be detected, suggesting that the source of infecting 
pathogens in osteomyelitis of the jaws is likely to be 
gingivitis, chronic periodontitis, previous dental 
extractions or endodontic treatments [4, 5, 27]. Also 
pathogens different from those of the oral microbiota 
may reach the bone tissues through transient 
bacteremia, which are common after surgical 
procedures or traumas [28, 29]. We could however 
not ascertain the route of fungal infection which could 
have been either iatrogenic (following extraction) or 
due to inhalation of spores. 
Our patient’s case stresses the relevance of 
Apophysomyces elegans Complex as an emerging 
mucormycosis especially in the tropical and 
subtropical regions. A lack of awareness about fungal 
infections in most centers of developing countries 
underestimates its importance. It is a requirement that 
in an immunocompetent patient with maxillary 
osteomyelitis from tropical areas, one should rule out 
Apophysomyces infection. While the clinical 
presentations, outcomes and treatment strategy of 
osteomyelitis caused by this fungus are similar to 
other infections, this emerging trend of fungal infection 
emphasizes the need to be cognizant that 
mucormycosis may occur in an immunocompetent 
host, especially following trauma or extraction. 
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